Hong Bo Lu
Director/Board Member chez ARROWHEAD PHARMACEUTICALS, INC.
Fortune : 963 248 $ au 31/03/2024
Profil
Hong Bo Lu is currently a Director at Beijing PINS Medical Co., Ltd., Shanghai Rarestone Health Tech Group Co. Ltd., Ablaze Pharmaceuticals, Centrexion Therapeutics Corp., Pins Medical, Inc., Rgenta Therapeutics, Inc., Arrowhead Pharmaceuticals, Inc., Avistone Pharmaceuticals, Rarestone Group, Terns Pharmaceuticals, Inc., RiboX Therapeutics, Inc., Visirna Therapeutics, Inc., Zenas Pharma, Inc., and Vivo Capital LLC.
In the past, Dr. Lu served as a Managing Director at OrbiMed Advisors LLC from 2011 to 2016.
She also held positions as a Director at Crown Bioscience, Inc., Crown Bioscience International, Elpiscience Biopharma Ltd., and Geneception, Inc. Additionally, she was a Director at Passage Bio, Inc. and served as an Independent Director at Avedro, Inc. from 2018 to 2019.
Dr. Lu was an Independent Non-Executive Director at Turning Point Therapeutics, Inc. from 2017 to 2019 and a Non-Executive Director at Echosens SA from 2015 to 2018.
She worked as a Vice President & Senior Research Analyst at Piper Sandler & Co. (Broker) from 2010 to 2011.
Furthermore, she served as a Managing Partner at LAV Management Co., Ltd.
from 2017 to 2020.
Dr. Lu's education includes a graduate degree from Tsinghua University in 1995, a doctorate degree from the University of Washington in 2000, an undergraduate degree from Tsinghua University in 1993, and an MBA from the Haas School of Business in 2005.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/03/2024 | 33 680 ( 0,03% ) | 963 248 $ | 31/03/2024 | |
| 12/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Hong Bo Lu
| Sociétés | Poste | Début |
|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Director/Board Member | 01/01/2019 |
| TERNS PHARMACEUTICALS, INC. | Director/Board Member | 01/04/2020 |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 01/04/2024 |
Beijing PINS Medical Co., Ltd.
 Beijing PINS Medical Co., Ltd. Medical SpecialtiesHealth Technology Beijing PINS Medical Co., Ltd. is a medical company based in Beijing, China. The Chinese company's main focus is on pinch medical. The company was founded in 2008. The CEO is Hongwei Hao. | Director/Board Member | - |
RiboX Therapeutics, Inc.
 RiboX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RiboX Therapeutics, Inc. engages in the development of fully engineered circular RNA therapeutics. The private company is based in Shanghai, China. | Director/Board Member | - |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Director/Board Member | - |
Visirna Therapeutics, Inc.
 Visirna Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Visirna Therapeutics, Inc. manufactures and commercializes RNAi-based investigational cardiometabolic medicines. The company is based in Shanghai, China. | Director/Board Member | - |
Avistone Pharmaceuticals
 Avistone Pharmaceuticals BiotechnologyHealth Technology Avistone Pharmaceuticals is a Chinese clinical-stage biotechnology company that specializes in precision oncology therapeutics. The company is located in China. | Director/Board Member | - |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Director/Board Member | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Anciens postes connus de Hong Bo Lu
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Hong Bo Lu
| University of Washington | Doctorate Degree |
| Tsinghua University | Graduate Degree |
| Haas School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| Entreprise privées | 22 |
|---|---|
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Finance |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Finance |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Finance |
Avedro, Inc.
 Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Echosens SA
 Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Health Technology |
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
Beijing PINS Medical Co., Ltd.
Beijing PINS Medical Co., Ltd. Medical SpecialtiesHealth Technology Beijing PINS Medical Co., Ltd. is a medical company based in Beijing, China. The Chinese company's main focus is on pinch medical. The company was founded in 2008. The CEO is Hongwei Hao. | Health Technology |
| Terns Pharmaceuticals, Inc. | |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
Rgenta Therapeutics, Inc.
 Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Rgenta Therapeutics, Inc. manufactures medicines for oncology and neurological disorders. The company was founded by Simon Xi, Travis Wager, and Zhiping Weng and is headquartered in Cambridge, MA. | Health Technology |
Geneception, Inc.
 Geneception, Inc. BiotechnologyHealth Technology Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA. | Health Technology |
| Pins Medical, Inc. | |
Ablaze Pharmaceuticals
 Ablaze Pharmaceuticals Pharmaceuticals: MajorHealth Technology Ablaze Pharmaceuticals is a Chinese clinical-stage pharmaceutical company founded in 2021 with a mission to bring advanced targeted radiopharmaceutical therapies to benefit cancer patients. Ablaze Pharma has secured a partnership with Rayzebio, Inc., an innovative radiopharmaceutical company based in CA, to gain exclusive development and commercial rights to a series of Rayzebio's products in the greater region. The company is based in Jing'an District, China. The company leverages its team's extensive business experience and network in cross-border product development and deal making to become the leader and partner of choice in the emerging TRT market. Alex Qiao has been the CEO of the company since 2021. | Health Technology |
Avistone Pharmaceuticals
Avistone Pharmaceuticals BiotechnologyHealth Technology Avistone Pharmaceuticals is a Chinese clinical-stage biotechnology company that specializes in precision oncology therapeutics. The company is located in China. | Health Technology |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Health Technology |
RiboX Therapeutics, Inc.
RiboX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology RiboX Therapeutics, Inc. engages in the development of fully engineered circular RNA therapeutics. The private company is based in Shanghai, China. | Health Technology |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Health Technology |
Visirna Therapeutics, Inc.
Visirna Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Visirna Therapeutics, Inc. manufactures and commercializes RNAi-based investigational cardiometabolic medicines. The company is based in Shanghai, China. | Health Technology |
